Retension Pharmaceuticals
RTSN
#9628
Rank
HK$0.84 B
Marketcap
HK$101.98
Share price
-6.34%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Retension Pharmaceuticals (RTSN)

Market cap: HK$0.84 Billion

As of November 2026 Retension Pharmaceuticals has a market cap of HK$0.84 Billion. This makes Retension Pharmaceuticals the world's 9628th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Retension Pharmaceuticals in 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.84 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Retension Pharmaceuticals was reported to be:

HK$0.90 Billion
by Nasdaq info icon info icon
HK$0.84 Billion
by CompaniesMarketCap info icon info icon